In vitro conversion of surfactant subtypes is altered in alveolar surfactant isolated from injured lungs.
about
Rapid-Onset Acute Respiratory Distress Syndrome (ARDS) in a Patient Undergoing Metastatic Liver Resection: A Case Report and Review of the LiteratureEffects of smoke inhalation on alveolar surfactant subtypes in miceCurrent concepts on the pulmonary surfactant in infants.Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?Surfactant and the adult respiratory distress syndrome.Toxic oxidant species and their impact on the pulmonary surfactant system.Inhaled nitric oxide decreases hyperoxia-induced surfactant abnormality in preterm rabbits.Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates.Surface-area cycling of different surfactant preparations: SP-A and SP-B are essential for large-aggregate integrity.Surfactant-associated protein A is important for maintaining surfactant large-aggregate forms during surface-area cycling.Surface properties, morphology and protein composition of pulmonary surfactant subtypes.Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.Effects of ventilation style on surfactant metabolism and treatment response in preterm lambs.Protein inhibition of surfactant during mechanical ventilation of isolated rat lungs.Hyperoxia treatment of TREK-1/TREK-2/TRAAK-deficient mice is associated with a reduction in surfactant proteins.Convertase activity in alveolar surfactant and lamellar bodies in fetal, newborn, and adult rabbits.Artificial surfactant (Surfactant TA) modulates adherence and superoxide production of neutrophils.
P2860
Q34097476-EC76031D-9888-49B0-9F3A-013CD9F1C1A4Q35833827-E6D4EBDC-2978-43C5-8E2C-758E28DCA855Q36359561-92371E8C-27B0-40B6-A5D1-B9AFD7D3A8C3Q36902581-9AE39D20-1AB0-4D20-8654-9747E36AD587Q40869111-9EF2FD84-CF55-4D7C-9AF5-ABF96F84D773Q41355904-9920A73D-3218-43F4-BF0B-0AA554A95832Q41607381-90E934BF-C73F-4FC3-9823-BB22FB5617E5Q42814793-7E50BC46-91EE-4066-B9C7-253ECBADB4FAQ42834889-5AF1855B-6A24-474A-9BEB-52E1D52CC451Q42980834-65DDCCD6-5B83-47F8-93C0-42C2AFFEBC21Q42984787-C45E4623-E008-46FA-B341-C55ECC9B95DAQ44257779-A9461599-2CB1-44B9-8D30-22D31BE3985CQ46878750-1909D868-6652-41E3-B7D3-F4A5E99912A2Q47716759-4FBC0CEB-D568-4C0A-9F2D-3422A81EA2A0Q47793284-16EB5E46-1AD3-45A3-B573-B537004C4E5AQ52180564-0F11A36B-301A-4610-95F8-222BA87EBD28Q54113369-5769FB23-852D-4936-B788-47230E12E3F0
P2860
In vitro conversion of surfactant subtypes is altered in alveolar surfactant isolated from injured lungs.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
In vitro conversion of surfact ...... t isolated from injured lungs.
@en
In vitro conversion of surfact ...... t isolated from injured lungs.
@nl
type
label
In vitro conversion of surfact ...... t isolated from injured lungs.
@en
In vitro conversion of surfact ...... t isolated from injured lungs.
@nl
prefLabel
In vitro conversion of surfact ...... t isolated from injured lungs.
@en
In vitro conversion of surfact ...... t isolated from injured lungs.
@nl
P2093
P2860
P356
P1476
In vitro conversion of surfact ...... t isolated from injured lungs.
@en
P2093
P2860
P304
P356
10.1164/AJRCCM/145.6.1416
P577
1992-06-01T00:00:00Z